Centene Corp

Most Recent

  • uploads///Graph
    Miscellaneous

    The Aetna-Humana Deal: Must-Know Risks to Consider

    On July 3, 2015, Aetna announced the acquisition of its peer, Humana (HUM), for a consideration of $37 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Centene–Health Net Deal: Potential Risks

    With the health insurance industry witnessing a wave of consolidations, it is expected that a majority of acquirers may risk overpaying for their targets.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Analysts’ Recommendations for Anthem in 2017

    Based on the company’s performance in 1Q17, Anthem (ANTM) has increased its 2017 revenue guidance by around $1.5 billion.

    By Margaret Patrick
  • uploads///Part  Graph
    Company & Industry Overviews

    Healthcare Sector Updates for May 22–26, 2017

    If the US Senate passes the AHCA, the CBO estimates that ~23 million people could become uninsured by 2026. The CBO projects that Medicaid spending could fall $880 billion in the next ten years.

    By Alexis Tate
  • uploads///Graph
    Earnings Report

    Medicaid Enrollments Drove Centene’s Revenues in 2015—But Which Way?

    In 4Q15, Centene’s Medicaid enrollments witnessed a solid YoY growth of about 24.5%, reaching about 5 million.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    UnitedHealthcare Adds 1.6 million Enrollments Year-over-Year

    UnitedHealthcare grew its Medicare business by 3,80,000 new enrollees, with enrollments distributed almost evenly between MA (Medicare Advantage) and supplemental Medicare plans.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Centene’s Hunt for New Growth Opportunities in Existing Markets

    Centene believes that if all its existing markets adopt Medicaid expansion, it would result in 4 million additional members becoming eligible for Medicaid.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Managing the Revenue Expectations for Centene’s New Market Entry Strategy

    To ensure high-profit margins through 2017, Centene plans to enter new markets across its Medicaid, long-term care, and correctional health businesses.

    By Margaret Patrick
  • uploads///Graph
    Healthcare

    Centene and Wellcare Health Plans: The Word on Wall Street

    Wall Street analysts expect an upside potential of 53.80% for Centene (CNC), based on the company’s trading price of $51.06.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Centene’s Specialty Services Strategy Portfolio: Backbone or Achilles Heel?

    Centene has developed a specialty services portfolio that reduces the company’s over-reliance on Medicaid and other state-sponsored businesses.

    By Margaret Patrick
  • uploads///Part  Graph
    Company & Industry Overviews

    XLV Gains May 10, Trades above Its 20-Day Moving Average

    On May 10, 2016, the top gainers of XLV were Allergan (AGN) and Regeneron Pharmaceuticals (REGN). They rose by 5.3% and 2.8%, respectively.

    By Peter Neil
  • uploads///Graph
    Earnings Report

    Key Takeaways from Centene’s 1Q15 Earnings Release

    Centene (CNC) posted its 1Q15 earnings on April 28, 2015. The company beat the Wall Street diluted EPS estimates of $0.49 with a posted EPS of $0.52.

    By Margaret Patrick
  • uploads///AdobeStock_
    Consumer

    David Tepper’s Appaloosa: Analyzing Its Top Holdings

    In the third quarter, David Tepper’s Appaloosa included three new stocks, exited five securities, and increased its stake in the existing eight stocks.

    By Rabindra Samanta
  • uploads///ambulance architecture building
    Company & Industry Overviews

    Healthcare Stocks to Watch Amid the ACA Constitutionality Debate

    On July 9, the Affordable Care Act’s constitutionality was debated in the US Court of Appeals. How did healthcare stocks react?

    By Margaret Patrick
  • uploads///adult career clipboard
    Company & Industry Overviews

    This Rebate Decision Saw Health Insurers Soar Yesterday

    On Thursday, the Trump administration announced the withdrawal of the proposal to abolish rebates paid to pharmacy benefit managers by drugmakers.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What’s Centene Expecting of Its Medicare and Medicaid Businesses?

    On its first-quarter earnings conference call, Centene (CNC) guided for almost flat MA (Medicare Advantage) memberships in 2019.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Comparing Expense Trends for CNC and HUM in 2019

    In its first-quarter earnings press release, Centene (CNC) reiterated its 2019 HBR (health benefits ratio) guidance of 86.5%–87.0%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Comparing EPS Growth Trends for CNC and HUM in 2019

    In its first-quarter earnings press release, Humana narrowed its 2019 non-GAAP EPS guidance due to the better-than-expected performance of its Retail segment.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Comparing CNC’s and HUM’s Revenue Growth Trends in 2019

    In its first-quarter earnings press release, Centene (CNC) revised its 2019 revenue guidance upward to $72.8 billion–$73.6 billion.

    By Margaret Patrick
  • uploads///medical _
    Company & Industry Overviews

    What Analysts Are Recommending for CNC and HUM in May

    Analysts’ consensus recommendations for both Centene and Humana are “buys.”

    By Margaret Patrick
  • uploads///calculator _
    Fund Managers

    Why Dan Loeb’s Third Point Has Built a Stake in Centene

    On May 24, the Wall Street Journal reported that Daniel Loeb’s Third Point had built a stake in health insurer Centene (CNC).

    By Anuradha Garg
  • uploads///Graph
    Earnings Report

    Centene Revises Its 2019 EPS Guidance Upward

    On its first-quarter earnings conference call, Centene (CNC) guided for 2019 adjusted diluted EPS of $4.24–$4.44.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Centene Revises Its 2019 Revenue Guidance Upward

    On its first-quarter earnings conference call, Centene (CNC) guided for 2019 revenue in the range of $72.8 billion–$73.6 billion.

    By Margaret Patrick
  • uploads///family _
    Company & Industry Overviews

    What Are Analysts Recommending for CNC and UNH?

    The 12-month consensus recommendation for both Centene and UnitedHealth Group is a “buy.”

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    A Look at Synergies from the Centene-WellCare Deal

    Centene expects the combined company to be the number one player in the Medicaid business.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Centene’s Fidelis Acquisition on Track to Achieve Synergy Targets

    On July 2, 2018, Centene (CNC) issued a press release announcing the completion of the acquisition of Fidelis Care, a leading government health plan in New York City,

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Here Is a Key Differentiator for Centene in Fiscal 2019

    Centene (CNC) highlighted its position as the national leader in the health insurance marketplace business with a presence in 16 states in the US.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    CNC or UNH: Who Has Better Earnings Growth Prospects?

    In its fourth-quarter earnings conference call, Centene (CNC) guided for fiscal 2019 GAAP diluted EPS of $3.65–$3.83.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Revenue Growth Prospects: What to Expect from CNC and UNH

    In fiscal 2018, Centene (CNC) reported revenues of $60.12 billion, a YoY rise of 24.25%.

    By Margaret Patrick
  • uploads///business _
    Healthcare

    Centene’s Acquisition of WellCare Health Plans: The Must-Knows

    Today, Centene (CNC) issued a press release announcing its plan to acquire WellCare Health Plans (WCG) for a total consideration of $17.3 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Medicaid Business—A Key Revenue Driver for WellCare Health Plans in 2017

    In 1Q17, WellCare Health Plans’ (WCG) Medicaid business reported revenues close to $2.6 billion, which equals year-over-year growth of ~11.8%.

    By Margaret Patrick
  • uploads///Healthcare Moves Have Been Muted Compared to Biotech
    Real Insights

    Healthcare Moves Have Been Muted, but Could We Get a Surprise?

    Rising interest rates don’t negatively affect healthcare as much as some other industries. But it has still underperformed since the US elections.

    By Direxion
  • uploads///Graph
    Earnings Report

    Why Anthem’s Benefit Expense Ratio Rose in 1Q17

    Expense guidance for 2017 For full-year 2017, Anthem (ANTM) has projected the medical cost trend for its local group business to fall in the range of 6.5%–7.0%. To learn more about medical cost trends, please see Medical cost trend means rising premiums for health insurance. If Anthem’s actual medical cost trend for full-year 2017 turns out […]

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Why Centene’s Health Benefit Ratio Improved in 1Q17

    Centene (CNC) has projected its health benefit ratio (or HBR) for the full year 2017 to fall in the range of 87.0% to 87.5%.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Centene Saw Robust Rise in Medicaid Enrollments in 1Q17

    In 1Q17, around 12.1 million members were enrolled in Centene’s (CNC) various healthcare plans, which is a year-over-year (or YoY) rise of around 600,000 beneficiaries.

    By Margaret Patrick
  • uploads///US High Yield Bond Fund Flows
    Company & Industry Overviews

    Is It Time to Offload High Yield Bond Mutual Funds?

    High yield bonds are closer in behavior to equities than other types of bonds. Year-to-date in 2016, WHIAX has fallen 4.3%, and the S&P 500 has fallen 4.5%.

    By David Ashworth
  • uploads///Graph
    Earnings Report

    Will Increasing Scale and Diversification Boost Centene’s Revenues?

    After the closure of Centene-Health Net Deal, Centene expects to benefit from increased scale of operations and diversification of revenue base.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    What Subsidy Eligible Membership Could Mean for Centene’s Public Exchange Revenues

    Centene managed to increase its public exchange membership from 75,000 members in 2015 to 146,000 members in 2015.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    How Did Centene’s Geographical Diversification Strategy Boosts Pan out for Its 4Q15 Earnings?

    Centene posted its 4Q15 and 2015 earnings on February 09 and reported diluted operating EPS attributable to common shareholders of about $2.89 for 2015.

    By Margaret Patrick
  • uploads///US High Yield Bond Fund Flows
    Company & Industry Overviews

    High-Yield Bond Funds Witness Inflows, Yield on Bonds Fell

    Investor flows into high-yield bond funds were positive in the week ended January 29, 2016, after three consecutive weeks of outflows.

    By Lynn Noah
  • uploads///Junk Bond Yields in  and
    Company & Industry Overviews

    Junk Bond Issuance Has Gained Traction

    The strong secondary market performance of the junk bond issues priced so far in 2016 built investor confidence. It helped them take positions in low quality and highly leveraged junk bonds.

    By Lynn Noah
  • uploads///Graph
    Earnings Report

    Humana Acquisition Could Be Aetna’s Key Long-Term Growth Driver

    Aetna’s Humana acquisition is mainly aimed at increasing the combined companies’ exposure to the high-growth Medicare business. The deal is currently being scrutinized by antitrust regulators.

    By Margaret Patrick
  • uploads///cnc pm
    Earnings Report

    Centene’s Revenue and Income Rose in 3Q15

    Centene has reported net revenue of $5,821 million in 3Q15, an increase of 5.7% compared to $5,506 million in 2Q15. Operating revenue increased 5.8% in 3Q15.

    By Gabriel Kane
  • uploads///Graph
    Miscellaneous

    Is UnitedHealth Group a Better Partner for Cigna?

    Based on market capitalization, UnitedHealth Group appears to be a stronger partner for Cigna.

    By Margaret Patrick
  • uploads///Graph
    Miscellaneous

    Synergies in Centene’s Acquisition of Health Net

    Centene projects that Health Net’s acquisition will help Centene realize pre-tax synergies worth $150 million by the end of the second year after the closure of the deal.

    By Margaret Patrick
  • uploads///Graph
    Miscellaneous

    Analyzing the Market’s Response to the Centene–Health Net Deal

    The Centene–Health Net deal is expected to be completed by early 2016, pending approval by the shareholders of both companies.

    By Margaret Patrick
  • uploads///Graph
    Miscellaneous

    Centene–Health Net Entity Could Be Medicaid Leader

    Centene aims to position itself as a leader in the fast-growing Medicaid market. Health Net’s acquisition will add ~1.7 million Medicaid members to the company’s portfolio.

    By Margaret Patrick
  • uploads///Graph
    Miscellaneous

    Centene Announces Its Acquisition of Health Net

    On July 2, Centene announced the acquisition of Health Net for a combination of cash and shares amounting to $6.8 billion. This includes the assumption of Health Net’s $500 million debt.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What Are Centene’s Key Risks?

    Centene (CNC) faces a unique combination of business risks as well as risks specific to the health industry (IYH). Centene has a highly concentrated business mix.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Medical Care Ratio – Centene Compared to Its Peers

    For health insurance companies, the medical care ratio is the ratio of total money spent on healthcare claims to premiums earned—adjusted for tax and regulatory expenses.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Anthem’s Medical Care Ratio Improves, Boosts Profit Margin

    Anthem’s medical care ratio declined from 87.8% in 2013 to 83.1% in 2014, as a result of its favorable enrollment mix.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Specialty Services: How Does Centene Manage Them?

    Aside from the standard healthcare policies, players—like Centene—in the private health insurance industry (IYH) also offer specialty insurance.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What’s Centene’s Business Strategy?

    Centene’s business strategy focuses on improving the quality of its services. It provides services to the uninsured and underinsured population in 22 states in the US.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What Are Centene’s Key Business Segments?

    Centene operates local health plans. Its Managed Care segment offers health insurance services to individuals through government-subsidized programs.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Centene: Insurance Exchange Opportunity and Hybrid Plans

    In 2014, Centene entered into a contract with Arkansas to participate in a hybrid Medicaid program. The program is expected to expire in December 2015.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cigna Diversifies Via Mergers and Acquisitions

    Among Cigna’s major strategic mergers and acquisitions was HealthSpring, acquired in 2012 for a consideration of $3.8 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Anthem’s Key Business Segments

    In 2014, of Anthem’s three business segments, Commercial and Specialty accounted for 53.7% of total revenues, and Government Business contributed 46.3%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Anthem: One of America’s Largest Health Insurance Providers

    Anthem provides health benefits and services to about 69 million people through its affiliated companies. It came 38th in the 2014 Fortune 500 rankings.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Must-Know: Aetna’s Key Mergers and Acquisitions

    Aetna’s M&A strategy is mainly targeted at expanding the company’s markets and building its technology capabilities.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Cigna: Medicare and Medicaid Beneficiaries Top Earners

    Most of Cigna’s revenue comes from insurance for employer-sponsored as well as Medicare and Medicaid beneficiaries.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Shift to self-insurance plans affects health insurance stocks

    As hospital utilization remains low, more employers are exploring the option of self-insurance to reduce their employee benefit costs.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    The rise in insurance demand can benefit managed care stocks

    With 26 million uninsured people expected to gain insurance by 2017 due to the Affordable Care Act, the US is seeing a rise in health insurance demand.

    By Margaret Patrick
  • Healthcare

    Molina Healthcare: Why Medicaid growth should directly help Molina

    Molina Healthcare, Inc. (MOH): Market overview Medicaid is a rapidly growing segment within healthcare, which should directly benefit MOH. In addition to typical market growth of mid-single digits, there are several supplemental drivers. Healthcare reform (Obamacare) Under current reform provisions starting 2014, Medicaid would expand coverage to additional 11 thousand uninsured. Based on its presence within […]

    By Samuel Madden, CFA
  • Healthcare

    Molina Healthcare: Why Molina’s revenues have been growing fast

    Molina Healthcare, Inc. (MOH): Revenue growth In general, Medicaid health plans grow revenue by increasing their membership or generating higher rates from state governments. The latter portion is often left up to negotiations between plans and states. States often have the final say, but given cost savings managed care can generate, they are loathe to bring […]

    By Samuel Madden, CFA
  • uploads///MOH Enrollment by Product
    Healthcare

    Molina Healthcare: The company’s foothold in a growing market

    As one of the leading Medicaid-focused HMOs, MOH enjoys a strong foothold in one of the healthcare sector’s fastest-growing markets.

    By Samuel Madden, CFA
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.